Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous angiosarcoma as a second malignant neoplasm after peripheral primitive neuroectodermal tumor.

C M Coffin1, T J Vietti, V J Land

  • 1Department of Pathology, Washington University School of Medicine, St. Louis, MO.

Medical and Pediatric Oncology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial extramedullary hematopoiesis following myocardial infarction.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.

Oncogene·2014
Same author

CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.

The British journal of dermatology·2009
Same author

Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1.

Journal of medical genetics·2009
Same author

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.

The Journal of pathology·2006
Same author

Lipofibromatosis presenting as a pediatric neck mass.

International journal of pediatric otorhinolaryngology·2004

Survivors of childhood cancer can develop second malignant neoplasms (SMN) due to therapy. This case highlights an uncommon combination of soft tissue sarcomas in a young patient, emphasizing the long-term risks of cancer treatment.

Area of Science:

  • Oncology
  • Cancer Survivorship Research
  • Pediatric Oncology

Background:

  • Second malignant neoplasms (SMN) are a recognized late effect in childhood cancer survivors.
  • Therapies like radiation and chemotherapy, including alkylating agents and antimetabolites, are associated with increased SMN risk.
  • Soft tissue sarcomas are common primary malignancies complicated by SMN.

Observation:

  • A 17-year-old patient was diagnosed with a peripheral neuroepithelioma (primitive neuroectodermal tumor, PNET) of the soft tissues.
  • The patient received high-dose irradiation and multidrug chemotherapy for the initial PNET.
  • Fourteen years post-treatment, the patient developed a secondary angiosarcoma.

Findings:

  • This case presents an unusual occurrence of two distinct mesenchymal malignancies in a young patient.

Related Experiment Videos

  • The patient experienced a favorable clinical course following the initial PNET diagnosis and treatment.
  • The temporal development of angiosarcoma suggests a potential link to prior cancer therapies.

    • Implications:

    • This case underscores the importance of long-term surveillance for secondary malignancies in childhood cancer survivors.
    • Understanding the specific risks associated with different treatment modalities is crucial for optimizing survivorship care.
    • Further research into the mechanisms underlying therapy-induced SMN is warranted.